temoporfin has been researched along with Bile Duct Cancer in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, ZL; Gadoora, MA; Gao, YH; Li, MY; Meharban, F; Nyokong, T; Sajjad, F; Wang, JH; Yan, YJ | 1 |
Fabian, J; Herrmann, FC; Langer, K; Mulac, D; Stein, NC | 1 |
Berr, F; Denzer, UW; Emmanuel, K; Friesenbichler, P; Kiesslich, T; Lohse, AW; Neureiter, D; Puespoek, A; Wagner, A; Wolkersdörfer, GW | 1 |
Betz, CS; Göke, B; Kniebühler, G; Pongratz, T; Schirra, J; Sroka, R; Stepp, H | 1 |
Ortner, MA | 1 |
Ayaru, L; Bown, SG; Hatfield, AR; Mosse, A; Pereira, SP; Rogowska, A | 1 |
1 review(s) available for temoporfin and Bile Duct Cancer
Article | Year |
---|---|
Photodynamic therapy for cholangiocarcinoma: overview and new developments.
Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Hematoporphyrins; Humans; Interleukin-6; Mesoporphyrins; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Stents | 2009 |
2 trial(s) available for temoporfin and Bile Duct Cancer
Article | Year |
---|---|
Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts; Female; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents | 2013 |
Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)).
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Dose-Response Relationship, Drug; Female; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Stents; Survival Rate; Treatment Outcome | 2013 |
3 other study(ies) available for temoporfin and Bile Duct Cancer
Article | Year |
---|---|
Synthesis and pharmacological evaluation of chlorin derivatives for photodynamic therapy of cholangiocarcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Female; Humans; Light; Male; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Necrosis; Photochemotherapy; Photosensitizing Agents; Porphyrins; Xenograft Model Antitumor Assays | 2020 |
Nanoparticle albumin-bound mTHPC for photodynamic therapy: Preparation and comprehensive characterization of a promising drug delivery system.
Topics: Bile Duct Neoplasms; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Humans; Mesoporphyrins; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Serum Albumin, Bovine; Solubility | 2020 |
Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Stents; Survival Analysis; Treatment Outcome | 2007 |